Skeletal muscle index as a prognostic biomarker for survival in HER2-positive and triple-negative breast cancer: a retrospective cohort study
Sarcopenia assessed by BIA is an independent predictor of poor survival in breast cancer, particularly in HER2-positive and TNBC subtypes. Incorporating muscle assessment into routine evaluation may help identify high-risk patients and guide supportive care.
Authors
- Derya Hopancı Bıçaklı (ORCID: https://orcid.org/0000-0003-1594-3266)
- Oğuzcan Özkan (ORCID: https://orcid.org/0000-0002-4075-7775)
- Aslı Geçgel (ORCID: https://orcid.org/0000-0001-6942-9858)
- Erhan GÖKMEN
- Sevgi Erol
Institutions
- Ege University (TR)
Publication Details
- Journal
- BMJ Supportive & Palliative Care
- Published
- 2025-12-31
- DOI
- https://doi.org/10.1136/spcare-2025-005991
- Primary Topic
- Nutrition and Health in Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00